PROCEPT BioRobotics Corporation
$1.9M 8,013 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
CooperSurgical, Inc.
CooperSurgical, Inc. reported $1,926,508.39 across General Payments, Research, and Ownership to 9,542 physicians and teaching hospitals across 9,542 transactions.
- $1.9M Top quartile payer
- All-tracks total
- 9,542 Top quartile volume
- Transactions
- 9,542 Top quartile reach
- Recipients
- −$2.4M
- General Payments vs PY2023
CooperSurgical, Inc. reported $1,926,508.39 across all CMS Open Payments tracks (General + Research + Ownership) to 9,542 physicians and teaching hospitals in Program Year 2024 - ranking #454 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,926,508.39, averaging $201.90 per recipient.
CooperSurgical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
D
63/100
Total payments
F
28/100
Transaction volume
C
79/100
Physician reach
B
82/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer coopersurgical-inc CooperSurgical, Inc.
$1.9M · #454/1,925 · 0.0% industry · PY2024
- TOT $1.9M
- RANK #454
- SHARE 0.0%
- TXN 9,542
- RCP 9,542
- CAT 5
- GEN $1.9M
- ΔGEN −$2.4M
- TOP1 58.4%
- PY 2024
Volume peers
Nearest volume peer: PROCEPT BioRobotics Corporation ($1.9M)
CooperSurgical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
CooperSurgical, Inc.'s CMS-reported General Payments decreased by $2.4M (−55.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: COOPERSURGICAL, INC.PY2023: COOPERSURGICAL, INC.PY2024: CooperSurgical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,294,557.28
- PY2024
- $1,926,508.39
What the Data Shows for CooperSurgical, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For CooperSurgical, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
49 transactions worth $1.6M make "Royalty or License" the top general-payment category in the 5-category breakdown below, 81.9% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
CooperSurgical, Inc. made 5 types of general payments. "Royalty or License" is the largest category at $1.6M, 81.9% of General Payments.
CooperSurgical, Inc. reports 5 general-payment categories - the top three are Royalty or License (81.9%), Food and Beverage (11.7%), and Consulting Fee (6.0%). The remaining 2 categories make up 0.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How CooperSurgical, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $1.6M | 49 | 81.9% |
| Food and Beverage | $225.2K | 9,425 | 11.7% |
| Consulting Fee | $114.8K | 51 | 6.0% |
| Education | $5.3K | 2 | 0.3% |
| Travel and Lodging | $4.4K | 15 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,533,590.68 (79.6%) of $1,926,508.39 in this company's General Payments records across 7,054 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for CooperSurgical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Charles H. Koh
$1,125,110.72 across 4 reported transactions
- 2
Arnold Advincula
$202,572.00 across 8 reported transactions
- 3
Nathan Roberto Fischer
$146,861.46 across 5 reported transactions
- 4
Mark Deutchman
$33,637.73 across 11 reported transactions
- 5
Marco Pelosi
$25,408.77 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
CooperSurgical, Inc.'s spend rank (#454 of 1,925, top 24% by spend) and concentration rank (#489 of 1,838, top 27% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Polarean, Inc. : $131.4K total payments, HHI 3654
- AccuTec Blades Inc : $45.1K total payments, HHI 3645
- Epizyme, Inc. : $16.4K total payments, HHI 3641
- OrphAI Therapeutics Inc. : $24.4K total payments, HHI 3624
- Flume Catheter Company Inc. : $15.0K total payments, HHI 3600
- Skeletal Dynamics Inc : $2.8M total payments, HHI 3598
- CooperSurgical, Inc. (this company) : $1.9M total payments, HHI 3590
- Medicines360 : $319.8K total payments, HHI 3588
- Bausch Health US, LLC : $640.0K total payments, HHI 3581
- Canon Medical Systems Corporation : $74.1K total payments, HHI 3576
- Acarix USA Inc. : $215.3K total payments, HHI 3569
- Natus Medical Incorporated : $59.5K total payments, HHI 3565
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as CooperSurgical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about CooperSurgical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with CooperSurgical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Procyrion, Inc.
$1.9M 211 recipients
Compare payment profiles
Vasorum USA Inc.
$1.9M 59 recipients
Compare payment profiles
Acrotech Biopharma Inc.
$1.9M 1,589 recipients
Compare payment profiles
Applied Medical Resources Corporation
$1.9M 2,197 recipients
Compare payment profiles
Spark Therapeutics, Inc.
$1.9M 146 recipients
Compare payment profiles
Put this to use
CooperSurgical, Inc. ranks #454 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where CooperSurgical, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just CooperSurgical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.